STOCK TITAN

PhenixFIN Corporation 5.25% Notes due 2028 - $PFXNZ STOCK NEWS

Welcome to our dedicated page for PhenixFIN Corporation 5.25% Notes due 2028 news (Ticker: $PFXNZ), a resource for investors and traders seeking the latest updates and insights on PhenixFIN Corporation 5.25% Notes due 2028 stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PhenixFIN Corporation 5.25% Notes due 2028's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PhenixFIN Corporation 5.25% Notes due 2028's position in the market.

Rhea-AI Summary
PhenixFIN Corporation (PFX) reported a 23% growth in net asset value (NAV) per share in the first quarter of 2024, reaching $73.14 per share as of December 31, 2023. The company achieved a total investment income of $5.7 million, with a weighted average yield of 13.0% on debt and other income producing investments. However, the company had 4 portfolio company investments on non-accrual status with a fair market value of $8.9 million, indicating potential risks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
PhenixFIN Corporation 5.25% Notes due 2028

Nasdaq:PFXNZ

PFXNZ Rankings

PFXNZ Stock Data

2.30M
United States of America
NEW YORK